Cubist Systematic Strategies’s 4D Molecular Therapeutics FDMT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-84,172
| Closed | -$272K | – | 1796 |
|
2025
Q1 | $272K | Sell |
84,172
-364,659
| -81% | -$1.18M | ﹤0.01% | 1134 |
|
2024
Q4 | $2.5M | Buy |
448,831
+428,285
| +2,085% | +$2.39M | 0.02% | 537 |
|
2024
Q3 | $222K | Buy |
+20,546
| New | +$222K | ﹤0.01% | 1132 |
|
2023
Q3 | – | Sell |
-1
| Closed | -$18 | – | 2172 |
|
2023
Q2 | $18 | Sell |
1
-1,814
| -100% | -$32.7K | ﹤0.01% | 2201 |
|
2023
Q1 | $31.2K | Sell |
1,815
-14,317
| -89% | -$246K | ﹤0.01% | 2586 |
|
2022
Q4 | $358K | Buy |
+16,132
| New | +$358K | ﹤0.01% | 2369 |
|
2022
Q3 | – | Sell |
-23,568
| Closed | -$165K | – | 3696 |
|
2022
Q2 | $165K | Buy |
+23,568
| New | +$165K | ﹤0.01% | 3246 |
|
2022
Q1 | – | Sell |
-17,913
| Closed | -$393K | – | 3598 |
|
2021
Q4 | $393K | Buy |
+17,913
| New | +$393K | ﹤0.01% | 2615 |
|